Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE)

Keyphrases

• B Cells 100%
• Receptor Activation 100%
• Receptor Expression 100%
• Systemic Lupus Erythematosus 100%
• Complement Receptors 100%
• B Lymphocytes 100%
• Complement Cascade 100%
• Complement Receptor 2 75%
• Erythrocytes 50%
• In Vitro Alternatives 37%
• Alternative Activation 37%
• Reduced Expression 25%
• Systemic Lupus Erythematosus Patient 25%
• Normal B Cells 25%
• Flow Cytometry 12%
• Disease Activity 12%
• Receptor-interacting Protein Kinase 1 (RIPK1) 12%
• Alternative Complement Pathway 12%
• C3dg 12%
• Regulatory Proteins 12%
• Low Complement 12%
• SLE Disease Activity Index (SLEDAI) 12%
• Leukocyte Immune-type Receptors 12%
• Blood Leukocytes 12%
• Laboratory Tools 12%

Immunology and Microbiology

• B Cell 100%
• Systemic Lupus Erythematosus 100%
• Complement Receptor 100%
• Complement Receptor 2 54%
• Erythrocyte 36%
• In Vitro 27%
• Leukocyte 9%
• C3b 9%